Trillium Asset Management LLC Reduces Position in Encompass Health Co. (NYSE:EHC)

Trillium Asset Management LLC lessened its position in shares of Encompass Health Co. (NYSE:EHC) by 1.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 160,490 shares of the company’s stock after selling 2,302 shares during the quarter. Trillium Asset Management LLC’s holdings in Encompass Health were worth $14,821,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp grew its stake in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after buying an additional 21,329 shares during the last quarter. Geode Capital Management LLC grew its stake in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after buying an additional 20,547 shares during the last quarter. Copeland Capital Management LLC grew its stake in shares of Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after purchasing an additional 8,548 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Encompass Health by 16.9% in the 4th quarter. Thrivent Financial for Lutherans now owns 888,827 shares of the company’s stock valued at $82,083,000 after purchasing an additional 128,331 shares during the last quarter. Finally, Point72 Asset Management L.P. grew its stake in shares of Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after purchasing an additional 835,135 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on EHC shares. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Finally, KeyCorp lifted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Performance

Shares of EHC stock opened at $97.53 on Wednesday. The stock has a fifty day moving average price of $97.60 and a 200 day moving average price of $97.05. The stock has a market cap of $9.82 billion, a PE ratio of 21.87, a P/E/G ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 1 year low of $76.11 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.70%. Encompass Health’s dividend payout ratio is presently 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.